Interferon regulatory factor (IRF)-2 is a transcription factor involved in type I interferon (IFN-α/β) signaling. It has been reported that IRF-2 deficiency results in various immune dysfunctions. However, the role of IRF-2 in B cell functions needed to be elucidated. 
Introduction
Interferon regulatory factors (IRFs) have been identified as regulators of human IFN-β gene and have been shown to play a pivotal role in IFN-α/β production and its signaling in the innate immune system (1,2). In addition, they control B cell development, activation and plasma cell (PC) differentiation in the adaptive immune responses (3). and IRF-8 control immunoglobulin light chain gene rearrangement in the differentiation of B cells (4, 5) . IRF-8 also regulates pre-BCR expression (6) and differentiation to B2 and MZB cells in the spleen (7). Furthermore, IRF-4 and IRF-5 directly induce Prdm1 (coding Blimp-1) expression and initiate the PC development in the germinal centers (GC) (8,9).
In the IRF family, IRF-2 was originally identified as an antagonist of IRF-1 (2,10).
Further analyses revealed that IRF-2 competes with IFN-stimulated gene factor (ISGF) 3, hetero-trimer of STAT-1, STAT-2 and IRF-9, to bind ISGF-binding motif in promoters of IFN-α/β responsive genes, resulting in the suppression of IFN-α/β signals via IFNAR (2,11).
This antagonistic function is important in order to attenuate IFN-α/β receptor (IFNAR)-dependent signals evoked by spontaneously produced . In addition, IRF-2 binds to IFN-β and CIITA-pIV promoters and regulates their functions by competing with IRF-1 and Blimp-1 in cellular responses (16) (17) (18) .
Regarding immune cell development, IRF-2 -/-mice have been shown to lack CD4
5'-AGACGGCCGCATCTTCTTGTGC-3' and 5'-GCCACTGCAAATGGCAGCCC-3'.
For Western blot analysis, B cell lysates were prepared before or after LPS stimulation with lysis buffer [1% Triton X-100, 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, and 25 mM CaCl 2 ]. Samples were separated by 12% SDS-PAGE, transferred to Immobilon-P membranes (Millipore, Bedford, MA, USA), probed with anti-IRF-4 Ab and HRP-anti-Rab
IgG or HRP-anti-actin, and then visualized with LumiGLO chemiluminescent substrate (Cell Signaling Technology, Beverly, MA, USA).
Transduction of IRF-2 cDNA to LPS-activated B2 B cells.
IRF-2 cDNA was cloned into MSCV-based retroviral vector (a gift from Dr.
Tomohiro Kurosaki) containing EGFP downstream of the internal ribosomal entry site. The
Plat-E packaging cells were transiently transfected with retroviral vector with the Lipofectamine 2000 reagent (Invitrogen) to produce viral supernatant. Purified B2 B cells from IRF-2 -/-or and WT mice were stimulated with LPS for 1 d and transduced with retrovirus in the presence of 10 µg/ml polybrene. Two days after infection, EGFP + cells were sorted and cultured at 3.5 to 5 × 10 4 cells/well without stimuli. The supernatant for ELISA and total RNA for RT-PCR were collected 3 d later.
Statistical analysis
Data are expressed as the mean ± SD of triplicate cultures or the sum of individual experiments. Statistical significances were determined by the unpaired Student's t-test or one-way ANOVA. Differences were considered to be significant for p values < 0.05. All experiments were performed at least 3 times and representative results are shown.
Results

Reduced proliferation of IRF-2 -/-B cells in response to BCR-mediated stimulation in an IFNAR-dependent manner
We first examined B cell proliferative responses to various stimuli in vitro. Although B cells from both IRF-2 -/-and WT mice responded comparably to LPS, IRF-2 -/-B cells were severely impaired in their response to BCR-mediated stimulation (Fig. 1A) . However, the (Fig. 2B , left panels), followed by measuring the thickness of MZ (Fig. 2B, right panel) .
Similar results were obtained by the staining of MZ macrophages with ER-TR9 mAb (data not shown).
Defect in B2, but not MZB, cell responsiveness in IRF-2 -/-mice
We then re-examined proliferative responsiveness of B2 and MZB cells separately (Fig.3A) . The results showed that IRF-2 -/-B2 cells were incapable of proliferating in response to anti-IgM, but responded to LPS more vigorously than WT B2 cells (Fig. 3A, left (Fig. 3B) .
In regard to Ab production, the B2, but not MZB, cell response to LPS was significantly impaired in IRF-2 -/- (Fig. 3C) , although there was good proliferation (Fig. 3A) .
In contrast to Ab production, the differentiation to PC in phenotypes was unexpectedly augmented in IRF-2 -/-B2 cells (Fig. 3D ). This accelerated differentiation was also seen in To confirm the role for IRF-2 in Blimp-1 induction and Ab production, we retrovirally transduced IRF-2 cDNA into IRF-2 -/-B2 cells. Complementation of IRF-2 indeed augmented Blimp-1 expression ( Fig. 4C ) along with the elevation of Ab production (Fig. 4D ).
When WT B2 cells were transduced with IRF-2 cDNA, Blimp-1 expression was further upregulated (Fig. 4E ), but IgM production was not affected (Fig. 4F ). Perhaps the amounts of Blimp-1 in WT B2 cells were already sufficient to induce IgM production. These results suggest that IRF-2 is deeply involved in Prdm1 upregulation and Ab production in B2 cells.
Reduced Ab production in response to TD, but not TI-2 antigen, in IRF-2 -/-mice
To investigate the role of IRF-2 in B cell function in vivo, we examined the Ab producing ability against TNP-Ficoll, a TI-2 antigen, and TNP-OVA/CFA, a TD antigen.
After a single injection of antigens, TNP-specific IgM and IgG in the sera of IRF-2 -/-mice were compared at 7 and 14 d with those of WT mice. In response to TNP-Ficoll, IRF-2 -/-and WT mice produced comparable levels of TNP-specific IgM and IgG (Fig. 5A ). In sharp contrast, Ab production, particularly that of IgM, to TD antigen was severely impaired at 7 and 14 d in the IRF-2 -/-mice ( Fig. 5B ). Although the IgG production was severely reduced at 7 d, it increased to significant, but still markedly low, levels as compared with those in WT mice at 14 d. Of note, the affinity maturation at 14 d was comparable between IRF-2 -/-and WT mice (Fig. 5C ).
Since high-affinity IgG Ab in response to TD antigen is produced by PCs generated in the germinal center (GC) (26), GC formation was also examined in IRF-2 -/-and WT mice.
Immunohistochemical staining of spleen sections at 14 d with PNA and anti-IgD demonstrated that GC formation in IRF-2 -/-mice was not severely impaired, although PNA + cells looked slightly sparse (Fig. 5D ). However, GC B cells identified as PNA + Fas + were not significantly reduced in IRF-2 -/-mice compared with WT mice (Fig. 5E ). In addition, there was no significant difference in apoptotic GC B cells between IRF-2 -/-and WT mice (data not shown). Consistent with GC formation and normal GC B cell development, comparable numbers of follicular helper T (Tfh) cells were present in the IRF-2 -/-spleen at 14 d (Fig. 5F ).
Moreover, IL-21 and Bcl-6 mRNA expression in CD4 + T cells was also comparable at 10 d between IRF-2 -/-and WT (Fig. 5G ).
To verify that the profoundly reduced Ab-producing response to TD antigen in the IRF-2 -/-mice could be attributed to B cell intrinsic defects, but not CD4 + T cell function, we transferred purified IRF-2 -/-or WT B cells to µMT mice and immunized these mice with TNP-OVA/CFA (Fig. 5H) . Neither IgM at 7 d nor IgG levels at 7 d or 14 d were fully restored in IRF-2 -/-B cell-reconstituted mice, indicating that the impaired Ab response in the IRF-2 -/-mice is due to intrinsic B cell defects. It should be noted that no measurable amounts of IgM were detected at 14 d in this experimental design (data not shown). These data suggest that IRF-2 is necessary for an optimal Ab response, likely at the level of antibody production, to TD antigen by B2 cells in vivo.
Discussion
The present study demonstrates that IRF-2 is involved in B2, but not MZB, cell proliferation and differentiation into Ab-producing PC induced by in vitro stimulation with anti-IgM and LPS, respectively. Importantly, IRF-2 contributes to these two B2 cell functions through different mechanisms. As in in vitro assays, the IRF-2 -/-mice responded normally to TI-2 Ag, but dramatically reduced IgM as well as IgG production in response to TD Ag in vivo.
With In humoral immune responses, B2 cells and MZB cells preferentially respond to TD and TI-2 antigens, respectively (25). As in in vitro studies, the IgM response to TD, but not TI-2, antigen was severely impaired in IRF-2 -/-mice at both 7 d and 14 d after immunization.
Unlike IgM production, fairly low but significant levels of IgG production was detected at 14 It has been shown that IRF-2 -/-mice can produce comparable levels of neutralizing IgM and IgG Abs to VSV (21). As IgM production to VSV is T cell-independent (32), our result in immunization with TI-2 antigen is consistent with this previous report. However, in contrast to our observations, the VSV-specific IgG response, which depends on CD4 + helper T cells (33), was reported to be normal in IRF-2 -/-mice. The reason for such a discrepancy is not clear, but we assume that adjuvant activities of VSV, the virus, and CFA containing mycobacteria may contribute to the Ab-producing adaptive immune responses.
Since antigen-specific IgM production by B2 cells is a key step in the production of IgG against TD antigen, the reduced IgG production to TNP-OVA/CFA in IRF-2 -/-mice may be attributable to a severely impaired extra-follicular IgM response at the earlier time points.
Given that IgM responses failed to be detected in IRF-2 -/-mice even on 14 d, when a considerable IgG response was observed, IRF-2 seems to be essential for extra-follicular production of IgM and important, but not mandatory, for later IgG production. n.s. n.s.
